CARA Message Board Post 10963758 | Cara Therapeutics Inc.
home / stock / cara / cara message board
StewartBuchanan
(investorshangout)
Posted on: Mar/28/2017 13:33:08
Source: investorshangout
https://investorshangout.com/post/view?id=4442111
Triple9: Cara Therapeutics Shares Eye New 1.5-Yr High on Positive Results in Part A of Phase 2/3 Trial For Ur
News, Short Squeeze, Breakout and More Instantly...
-
– Study achieved primary endpoint of Worst Itch-Numeric Rating Scale score change from baseline at Week 8 (p=0.001) – – Onset of action seen at Week 1 and sustained through Week 8 – – Statistical significance achieve...
-
KORSUVA™ (difelikefalin) injection U.S. commercial launch began in April 2022 and is tracking to expectation Kapruvia ® (difelikefalin) approved by European Commission for the treatment of moderate-to-severe pruritus associated with chronic kidney disease...
-
STAMFORD, Conn., May 03, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President an...